AbbVie Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	61,160	56,334	54,318	58,054	56,197
Revenue Growth (YoY)	8.57%	3.71%	-6.44%	3.30%	22.69%
Cost of Revenue	18,204	16,904	20,415	17,414	17,446
Gross Profit	42,956	39,430	33,903	40,640	38,751
Selling, General & Admin	14,010	14,752	12,872	15,260	12,349
Research & Development	9,096	12,791	7,675	6,510	6,922
Other Operating Expenses	4,775	2,750	599	753	1,556
Total Operating Expenses	27,881	30,293	21,146	22,523	20,827
Operating Income	15,075	9,137	12,757	18,117	17,924
Interest Expense	-2,627	-2,160	-1,684	-2,044	-2,384
Other Non-Operating Income (Expense)	-5,851	-3,261	-4,823	-2,596	-2,551
Total Non-Operating Income (Expense)	-8,478	-5,421	-6,507	-4,640	-4,935
Pretax Income	6,597	3,716	6,250	13,477	12,989
Provision for Income Taxes	2,364	-570	1,377	1,632	1,440
Net Income	4,226	4,278	4,863	11,836	11,542
Minority Interest in Earnings	7	8	10	9	7
Net Income to Common	4,226	4,278	4,863	11,836	11,542
Net Income Growth	-1.22%	-12.03%	-58.91%	2.55%	150.04%
Shares Outstanding (Basic)	1,769	1,769	1,768	1,771	1,770
Shares Outstanding (Diluted)	1,773	1,773	1,773	1,778	1,777
Shares Change (YoY)	-	-	-0.28%	0.06%	6.22%
EPS (Basic)	2.37	2.40	2.73	6.65	6.48
EPS (Diluted)	2.36	2.39	2.72	6.63	6.45
EPS Growth	-1.26%	-12.13%	-58.97%	2.79%	137.13%
Shares Outstanding	1,768	1,765	1,766	1,769	1,768
Free Cash Flow	17,816	17,832	22,062	24,248	21,990
Free Cash Flow Growth	-0.09%	-19.17%	-9.01%	10.27%	30.97%
Free Cash Flow Per Share	10.05	10.06	12.44	13.64	12.37
Dividends Per Share	6.650	6.290	5.990	5.710	5.310
Dividend Growth	5.72%	5.01%	4.90%	7.53%	9.71%
Gross Margin	70.24%	69.99%	62.42%	70.00%	68.96%
Operating Margin	24.65%	16.22%	23.49%	31.21%	31.89%
Profit Margin	6.92%	7.61%	8.97%	20.40%	20.55%
FCF Margin	29.13%	31.65%	40.62%	41.77%	39.13%
EBITDA	23,214	17,523	21,455	26,584	26,445
EBITDA Margin	37.96%	31.11%	39.50%	45.79%	47.06%
EBIT	15,075	9,137	12,757	18,117	17,924
EBIT Margin	24.65%	16.22%	23.49%	31.21%	31.89%
Effective Tax Rate	35.83%	-15.34%	22.03%	12.11%	11.09%

Updated Feb 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q